< Back to previous page
Researcher
Isabelle Huys
- Disciplines:Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences
Affiliations
- Clinical Pharmacology and Pharmacotherapy (Division)
Responsible
From17 Dec 2020 → Today - Faculty of Law and Criminology (Faculty)
Member
From1 Oct 2014 → 30 Sep 2015 - Clinical Pharmacology and Pharmacotherapy (Division)
Member
From1 Jul 2013 → Today - Toxicology and Pharmacology (Division)
Member
From1 Oct 1999 → 9 Mar 2004
Projects
1 - 10 of 50
- Collaborative licensing models for marine genetic resources in striving for efficient, accessible and equitable management of intellectual property rightsFrom12 Feb 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- How to create sustainable market access to advanced therapies?From1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- Organoid technologies for disease modeling, drug discovery and development for rare diseasesFrom1 Jan 2024 → TodayFunding: HORIZON.1.2 - Marie Skłodowska-Curie-actions (MSCA)
- Sustainable COVID-19 Vaccination for Long-term Vaccine Immunity and EffectivenessFrom1 Jan 2024 → TodayFunding: HORIZON.2.1 - Health
- Does patient empowerment foster access to and re-use of data in biomedical research, while allowing for meaningful protection of the fundamental right to data protection of patients?From1 Nov 2023 → TodayFunding: FWO junior postdoctoral fellowship
- What are the key factors needed for potential valorization of Marine Natural Products (MNPs)?From1 Nov 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Stakeholder Perspectives on Gene Therapy in CardiomyopathyFrom1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Shared decision-making for lung cancer prevention: patient-driven development and evaluation of a decision aid for patients and healthcare providersFrom11 Sep 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Shared decision-making for lung cancer prevention: patient-driven development and evaluation of a decision aid for patients and healthcare providersFrom1 Sep 2023 → TodayFunding: Foundations, funds and other with scientific goal
- Patient Experience Data for Innovative TherapiesFrom31 Aug 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
Publications
41 - 50 of 213
- Regulatory Information and Guidance on Biosimilars and Their Use Across Europe: A Call for Strengthened One Voice Messaging(2022)
Authors: Liese Barbier, Steven Simoens, Paul Declerck, Arnold Vulto, Isabelle Huys
- Qualitative Analysis of the Design and Implementation of Benefit-Sharing Programs for Biologics Across Europe(2022)
Authors: Teresa Barcina Lacosta, Arnold Vulto, Isabelle Huys, Steven Simoens
- Perceptions About Biosimilar Medicines Among Belgian Patients in the Ambulatory Care(2022)
Authors: Yannick Vandenplas, Liese Barbier, Steven Simoens, Arnold Vulto, Isabelle Huys
- Community pharmacists' preparedness for substituting biologics and dispensing biosimilars – Lessons learned from a multinational survey(2021)
Authors: Liese Barbier, Isabelle Huys
- Sustainable biosimilar competition: clinical, regulatory and policy insights(2021)
Authors: Liese Barbier, Isabelle Huys, Paul Declerck, Steven Simoens
- Patient preferences for gene therapy in haemophilia: Results from the PAVING threshold technique survey(2021)
Authors: Kathelijne Peerlinck, Steven Simoens, Isabelle Huys
Pages: 957 - 966 - R&D Costs of New Medicines: A Landscape Analysis(2021)
Authors: Steven Simoens, Isabelle Huys
- Patient Preferences in Drug Development and Evaluation: Issues and Recommendations(2021)
Authors: Rosanne Janssens, Isabelle Huys, Steven Simoens, Hilde Stevens
- Key Determinants of Health-Related Quality of Life Among Advanced Lung Cancer Patients: A Qualitative Study in Belgium and Italy(2021)
Authors: Rosanne Janssens, Elise Schoefs, Kristiaan Nackaerts, Isabelle Huys
- Patient Preferences in Rare Diseases: A Qualitative Study in Neuromuscular Disorders to Inform a Quantitative Preference Study(2021)
Authors: Isabelle Huys
Pages: 601 - 612